Introduction {#s1}
============

Meiosis is a specialized cell division program that generates haploid gametes from a diploid cell, in preparation for sexual reproduction. Meiosis achieves a two-fold reduction in ploidy through two successive cell divisions without an intervening DNA replication step. Homologous chromosomes segregate from one another in the first meiotic division (meiosis I), and replicated sister chromosomes segregate in meiosis II. Accurate segregation of homologs in meiosis I requires that homologs identify and physically link to one another in the extended meiotic prophase. Homolog recognition and physical association is achieved through crossover formation, in which programmed double strand DNA breaks (DSBs) in each chromosome are repaired in a specialized homologous recombination pathway, resulting in a reciprocal exchange of genetic information and the physical linkage of homologs.

A highly-conserved meiosis-specific structure, the chromosome axis, assembles in early meiotic prophase and provides a scaffold for the organization of chromosomes as a linear array of loops ([@bib89]; [@bib106]), and also orchestrates the formation of DSBs and their repair as inter-homolog crossovers ([@bib12]; [@bib32]; [@bib34]; [@bib37]; [@bib44]; [@bib43]; [@bib55]; [@bib56]; [@bib64]; [@bib77]; [@bib107]). Components of the chromosome axis include DNA-binding and -organizing cohesin complexes ([@bib60]), plus proteins of the meiotic HORMAD family that regulate DSB and crossover formation ([@bib2]; [@bib13]; [@bib15]; [@bib29]; [@bib48]; [@bib50]; [@bib87]; [@bib96]; [@bib105]). These proteins are named after their N-terminal HORMA ([Ho]{.ul}p1, [R]{.ul}ev7, [Ma]{.ul}d2) domain, a conserved fold that interacts with short sequence motifs termed 'closure motifs' ([@bib2]; [@bib71]). We have previously shown that meiotic HORMADs in *C. elegans* (HIM-3, HTP-1, HTP-2, and HTP-3) form a large oligomeric complex on the chromosome axis through interactions between their N-terminal HORMA domains and closure motifs in their C-termini ([@bib38]). We later showed that meiotic HORMAD proteins from both mammals (HORMAD1 and HORMAD2) and *S. cerevisiae* (Hop1) also possess putative closure motifs at their C-termini ([@bib38]; [@bib93]), suggesting that head-to-tail self-assembly of these proteins is conserved and important for their DSB- and crossover-promoting functions.

In addition to HORMAD proteins, most organisms also possess additional factors, here termed 'axis core' proteins after Moses ([@bib53]), that are important for axis formation and meiotic HORMAD recruitment. The archetypal axis core protein is *S. cerevisiae* Red1, an 827-residue protein that recruits the HORMAD protein Hop1 to the axis via a putative closure motif in its central region ([@bib93]; [@bib98]). A conserved region at the Red1 C-terminus is predicted to adopt a coiled-coil structure and mediates self-association of the protein ([@bib31]; [@bib98]), suggesting that oligomer formation by Red1 may also be important for axis function. While clearly-identifiable Red1 homologs do not exist outside fungi, many other organisms possess functionally-equivalent axis core proteins with predicted coiled-coil structure. Mammals possess two such proteins, SYCP2 (1500 residues in *Mus musculus*) and SYCP3 (254 residues), which are both required for proper axis formation and wild-type levels of crossovers ([@bib102]; [@bib103]), and are known to interact with one another through their C-terminal coiled-coil domains ([@bib100]). SYCP2 and SYCP3 are interdependent for their axis localization ([@bib65]; [@bib75]; [@bib100]; [@bib102]), and a mutant of SYCP2 lacking its C-terminal predicted coiled-coil region shows a loss of SYCP3 from the axis ([@bib75]; [@bib100]). These data suggest that the SYCP2 N-terminal region mediates localization of the complex, while the C-terminal domain mediates oligomerization with SYCP3. In plants, the axis proteins ASY3 (793 residues in *Arabidopsis thaliana*) and ASY4 (212 residues) are both important for crossover formation, and associate with one another through their C-terminal predicted coiled coil domains ([@bib14]; [@bib24]; [@bib62]). While neither SYCP2/SYCP3 nor ASY3/ASY4 have been reported to possess HORMAD-interacting closure motifs, the similar domain structure and roles in crossover formation between these proteins and *S. cerevisiae* Red1 suggests that they may be evolutionarily related ([@bib24]; [@bib59]).

In addition to its roles in chromosome organization and crossover formation in early meiotic prophase, the chromosome axis plays a later role as a key structural element of the highly-conserved yet functionally enigmatic synaptonemal complex (SC). As inter-homolog crossovers form, the chromosome axes of each homolog pair, now termed 'lateral elements' of the SC, become linked by coiled-coil 'transverse filaments' along their entire length ([@bib63]; [@bib68]; [@bib80]). In fungi, plants, and mammals, SC assembly is tightly coordinated with removal of the meiotic HORMADs from the chromosome axis by the AAA+-family ATPase Pch2/TRIP13, in a key feedback mechanism controlling crossover levels ([@bib7]; [@bib35]; [@bib42]; [@bib73]; [@bib88]). SC assembly is required for crossover maturation, and serves as a signal to the cell that a given homolog pair has obtained crossovers ([@bib63]; [@bib106]).

While the overall architecture of the SC---including the lateral elements, transverse filaments, and central element---are becoming better understood ([@bib10]; [@bib16]; [@bib18]; [@bib40]; [@bib49]; [@bib74]), the molecular interactions underlying the chromosome axis, and whether these interactions are conserved across eukaryotes, remain less well-characterized. Specifically, it is not known whether mammalian and plant axis core proteins possess HORMAD-binding closure motifs like Red1, leaving open the question of how HORMADs are recruited to chromosomes in these organisms. More significantly, the oligomeric structure of the axis core proteins, whether this structure is conserved, and how this structure contributes to the axis's roles in chromosome organization, inter-homolog recombination, and SC architecture are important open questions. Mammalian SYCP3 is known to form coiled-coil homotetramers ([@bib81]) that self-associate into larger structures both in cell culture ([@bib65]) and in vitro ([@bib81]), but how SYCP3 cooperates with SYCP2 to mediate chromosome localization and axis assembly is not known. Neither fungal Red1 nor plant ASY3/ASY4 have been characterized biochemically, leaving open the question of how these proteins self-assemble, and whether these assemblies resemble those of mammalian SYCP3.

Here, we address these questions and establish that the molecular architecture of the meiotic chromosome axis is shared between fungi, mammals and plants. We find that budding-yeast Red1 forms stable homotetrameric complexes via its coiled-coil C-terminus, and that these tetramers associate end-to-end to form extended filaments visible by electron microscopy. We identify HORMAD-binding closure motifs in both mammalian SYCP2 and plant ASY3, supporting these proteins' identification as Red1 homologs and strongly suggesting a role in meiotic HORMAD recruitment to meiotic chromosomes. We further show that both SYCP2/SYCP3 and ASY3/ASY4 form heterotetrameric coiled-coil complexes that self-assemble into extended filaments, paralleling our findings with Red1. Taken together, these data reveal common principles of meiotic chromosome axis assembly and function that are widely shared throughout eukaryotes.

Results {#s2}
=======

Budding Red1 forms filaments from coiled-coil tetramer units {#s2-1}
------------------------------------------------------------

In budding yeast, the chromosome axis is made up of the HORMAD protein Hop1, its binding partner Red1, and cohesin complexes containing the meiosis-specific kleisin subunit Rec8 ([@bib39]; [@bib106]). We and others have outlined the assembly mechanisms of Hop1, which binds short 'closure motifs' in its own C-terminal tail and in Red1 through its conserved HORMA domain ([Figure 1A](#fig1){ref-type="fig"}) ([@bib93]; [@bib98]). Red1 is less well-understood. This protein possesses a conserved N-terminal domain immediately followed by a Hop1-binding closure motif, an extended linker domain with high predicted disorder, and a C-terminal domain that mediates Red1 self-association and is predicted to adopt a coiled-coil structure ([Figure 1A](#fig1){ref-type="fig"}) ([@bib31]; [@bib93]; [@bib98]). Prior genetic studies isolated two point-mutations in the Red1 C-terminal domain, I743A ([@bib20]) and I758R ([@bib46]), that each strongly affect both SC assembly and spore viability in *S. cerevisiae*. While these phenotypes were attributed to effects on binding other meiotic chromosome-associated proteins, these residues' location within a predicted coiled-coil domain prompted us to consider instead that the observed defects may be due to disruption of a Red1 oligomer important for meiotic chromosome axis function.

![Molecular architecture of the budding-yeast Red1 C-terminal domain.\
(**A**) Schematic of *S. cerevisiae* (*Sc*) chromosome axis proteins Hop1 and Red1, and *Zygosaccharocmyces zouxii* (*Zr*) Red1. Yellow regions indicate Hop1-binding closure motifs ([@bib93]). For *S. cerevisiae* Red1, the positions of two previously-identified mutations in the C-terminal domain that disrupt axis function, I743A ([@bib20]) and I758R ([@bib46]), are shown. See [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"} for sequence alignment of the Red1 C-terminal domain. (**B**) SEC-MALS analysis of purified His~6~-MBP-*Zr* Red1^705-798^. Calculated molecular weight of a monomer = 55.9 kDa; Measured molecular weight = 4783 kDa (\~85 mer). (**C**) Representative negative-stain electron micrographs of purified untagged *Zr* Red1^705-798^. See [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"} for additional full micrographs, and [Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"} for micrographs of His~6~-MBP-*Zr* Red1^705-798^. (**D**) SEC-MALS analysis of purified His~6~-MBP-*Zr* Red1^705-791^ and His~6~-MBP-*Zr* Red1^705-798^ I715R. (**E**) SEC-MALS analysis of purified *Zr* Red1^705-791^ and *Zr* Red1^705-798^ I715R (as in panel D, but with His~6~-MBP tag removed). (**F**) Table summarizing SEC-MALS results from (**D**) and (**E**). (**G**) Schematic of *Zr* Red1 C-terminal domain oligomerization. Wild-type *Zr* Red1^705-798^ forms homotetramers that further oligomerize into extended filaments. Removal of the C-terminal seven amino acids (*Zr* Red1^705-791^) or mutations of I715 to arginine (*Zr* Red1^705-798^ I715R) results in loss of filament formation but maintenance of tetramer formation. (**H**) Representative surface-spread mid-meiotic prophase nuclei from wild-type (top row), and *red1* mutant alleles: *red1-Sc*^1-734^:*Zr*^707-798^ (second row), *red1-Sc*^1-734^:*Zr*^707-791^ (third row), and *red1-Sc*^1-734^:*Zr*^707-798 ^I715R\] (bottom row). Spore viability for each homozygous strain is shown in blue (n = 52--128, see Materials and Methods). Mid-meiotic prophase chromosomes are stained with DAPI to label DNA (white), anti-Red1 (magenta), and anti-Gmc2 (green). Scale bar, 1 μm. See [Figure 1---figure supplement 3B--E](#fig1s3){ref-type="fig"} for additional images. (**I**) Quantification of the distribution of Red1 on meiotic chromosomes at 3 hr and 5 hr after introduction into sporulation medium (n = 30--50 cells for each strain and time-point). 'foci + short linear'=cells with abundant foci and short linear stretches of Red1 staining; 'abundant foci'=cells with more than 25 strong Red1 foci; 'few foci'=cells with fewer than 25 weak Red1 foci. See [Figure 1---figure supplement 3F--H](#fig1s3){ref-type="fig"} for further quantification of Red1, Gmc2, and polycomplex assembly.](elife-40372-fig1){#fig1}

To test this idea, we expressed in *E. coli*, and purified the Red1 C-terminal domain from several budding yeasts, and found that uniformly, these proteins formed large assemblies as measured by size-exclusion chromatography ([Figure 1B](#fig1){ref-type="fig"} and data not shown). We examined one Red1 construct, *Zygosaccharomyces rouxii* (*Zr*) Red1^705-798^, by negative-stain electron microscopy. We observed filaments up to several microns in length ([Figure 1C](#fig1){ref-type="fig"}), suggesting that the large assemblies of purified Red1 C-terminal domain are not disordered aggregates but rather represent a biologically relevant structure. In the course of construct optimization, we also cloned and purified a truncated *Zr* Red1 construct missing the C-terminal seven residues of the protein (*Zr* Red1^705-791^). Strikingly, this construct did not form assemblies in solution, but rather formed stable homotetramers as measured by size-exclusion chromatography coupled to multi-angle light scattering (SEC-MALS; [Figure 1D--F](#fig1){ref-type="fig"}). Together, these data suggest that the Red1 C-terminal domain forms coiled-coil homotetramers that associate end-to-end to form extended filaments.

We next examined the effects of mutating *Zr* Red1 I715 and M730, which are equivalent to *Sc* Red1 I743 and I758, respectively. We mutated both residues to arginine and examined the effects by SEC-MALS. We found that the *Zr* Red1^705-798^ I715R mutant formed a homotetramer in solution, instead of the extended filaments formed by wild-type *Zr* Red1^705-798^ ([Figure 1D--F](#fig1){ref-type="fig"}). The *Zr* Red1^705-798^ M730R mutant was poorly behaved in solution, precluding a detailed analysis of this mutant's effects on filament formation. We next examined the effect of mutating I743 and I758 in *S. cerevisiae* Red1, which was soluble in vitro only when fused to a maltose binding protein (MBP) solubility tag. Using this system, we found that the wild-type *Sc* Red1 C-terminal domain (residues 731--827) forms large assemblies ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Mutating I743 to arginine disrupted higher-order assembly but maintained tetramer formation, and mutating I758 to arginine completely disrupted Red1 self-assembly resulting in monomers ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). We were unable to determine the effect of truncating the *Sc* Red1 C-terminus due to poor expression.

When combined with prior findings that the *Sc RED1*-I743A mutant shows low spore viability, our finding that mutating *Sc* Red1 I743 specifically disrupts filament assembly suggests that filament formation by Red1 may be critical for meiotic chromosome axis structure and function. To test this idea, we replaced the coiled-coil region of *S. cerevisiae* Red1 (residues 734--827) with the equivalent region of *Zr* Red1 (residues 707--798) to generate a chimeric Red1 protein (*red1-Sc*^1-734^:*Zr*^707-798^) that we could engineer with predictable effects based on our in vitro data. We next specifically disrupted filament formation in this chimeric construct by removing residues 792--798 (*red1-Sc*^1-734^:*Zr*^707-791^) or mutating *Zr* Red1 I715 to arginine (*red1-Sc*^1-734^:*Zr*^707-798^I715R). All three chimeric Red1 constructs were expressed equivalently to wild-type Red1 ([Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}), but only the full-length chimera supported appreciable levels of spore viability (54% viable spores for *red1-Sc*^1-734^:*Zr*^707-798^ versus 2% for *red1-Sc*^1-734^:*Zr*^707-791^ and 9% for *red1-Sc*^1-734^:*Zr*^707-798^I715R; [Figure 1H](#fig1){ref-type="fig"}). We next examined chromosome localization of the chimeric Red1 constructs in meiotic prophase, and their ability to support synaptonemal complex assembly. We found that the full-length chimeric protein (Red1-*Sc*^1-734^:*Zr*^707-798^) localized robustly to meiotic chromosomes and supported synaptonemal complex assembly, albeit less efficiently than wild-type Red1 ([Figure 1H--I](#fig1){ref-type="fig"}). Both truncation of the Red1 C-terminus (Red1-*Sc*^1-734^:*Zr*^707-791^) and the I715R mutation (Red1-*Sc*^1-734^:*Zr*^707-798^I715R) caused a strong defect in chromosome localization of Red1, and a near-complete loss of synaptonemal complex formation with a corresponding increase in polycomplex formation ([Figure 1H--I](#fig1){ref-type="fig"}, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). In both mutant strains, chromosomes were also less well-defined in DAPI staining than in either wild-type or Red1-*Sc*^1-734^:*Zr*^707-798^ cells ([Figure 1H](#fig1){ref-type="fig"}, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), suggesting defects in chromosome axis assembly and chromosome compaction. We conclude that Red1 filament formation is important for robust chromosome localization of Red1, and absolutely critical for proper assembly of the chromosome axis and, by extension, the synaptonemal complex. Finally, these data also suggest that the previously-identified deleterious effects of the *Sc* Red1 I743A and I758R mutations ([@bib20]; [@bib46]) may be due to disruption of Red1 filament assembly.

SYCP2 is an interaction hub for the mammalian chromosome axis {#s2-2}
-------------------------------------------------------------

The mammalian chromosome axis comprises cohesin complexes with several meiosis-specific subunits ([@bib5]; [@bib26]; [@bib92]; [@bib95]); two meiotic HORMAD proteins, HORMAD1 and HORMAD2 ([@bib25]); and the coiled-coil proteins SYCP2 and SYCP3 ([@bib45]; [@bib47]). We have previously shown that both HORMAD1 and HORMAD2 possess short motifs at their extreme C-termini that associate with these proteins' N-terminal HORMA domains ([@bib38]), strongly suggesting that these motifs constitute closure motifs equivalent to that previously identified in the *S. cerevisiae* Hop1 C-terminus ([@bib54]; [@bib93]). SYCP2 has been proposed as a distant homolog of budding-yeast Red1, and possesses a similar domain structure: an N-terminal ordered domain that may mediate the protein's association with chromosomes ([@bib23]), followed by an extended disordered region and a C-terminal domain of \~175 residues predicted to form a coiled-coil. Instead of self-associating like Red1, however, the SYCP2 coiled-coil domain binds the shorter coiled-coil protein SYCP3 ([Figure 2A](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) ([@bib82]; [@bib100]). Additionally, co-expression of SYCP2 and SYCP3 in cultured cells results in the assembly of large filamentous structures that incorporate both proteins, suggesting a capacity for self-assembly of SYCP2:SYCP3 complexes ([@bib65]).

![Protein-protein interactions and filament formation by mammalian SYCP2 and SYCP3.\
(**A**) Schematic of *M. musculus* (*Mm*) chromosome axis proteins, with underlines indicating fragments used for yeast two-hybrid analysis. The SYCP2 NTD (residues 1--394) forms a globular structure with unknown function ([@bib23]). See [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} for detailed coiled-coil and alpha-helix predictions of the SYCP2 and SYCP3 C-terminal domains. Yellow regions indicate putative HORMAD-binding closure motifs ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). (**B**) Yeast two-hybrid analysis of SYCP2 truncations versus SYCP3 and the HORMAD2 HORMA domain (residues 1-241). AD: Gal4 activation domain fusion; BD: Gal4 DNA-binding domain fusion. Stringent selection on -LEU-TRP-HIS-ADE (-LTHA) media is shown; see [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} for complete yeast two-hybrid results and for coexpression of SYCP2 fragments with HORMAD2^1-241^. (**C**) SDS-PAGE analysis of purified *Mm* SYCP2^1325-1500^:SYCP3^84-248^ complexes, with an N-terminal MBP tag on SYCP2 (left) or with the tag removed (right). (**D**) Representative negative-stain electron micrograph of purified *Mm* SYCP2^1325-1500^:SYCP3^84-248^. See [Figure 2---figure supplement 4A](#fig2s4){ref-type="fig"} for additional full micrographs. (**E**) Representative negative-stain electron micrographs of purified His~6~-MBP-*Mm* SYCP2^1325-1500^:SYCP3^84-248^. See [Figure 2---figure supplement 4B](#fig2s4){ref-type="fig"} for additional full micrographs. (**F**) Quantification of inter-MBP spacing in micrographs of His~6~-MBP-*Mm* SYCP2^1325-1500^:SYCP3^84-248^ filaments. The measured spacing of 23.1 ± 3.3 nm (mean ±standard deviation from 23 measured intervals) is equivalent to the length of a \~160 residue coiled-coil (0.146 nm rise per residue). (**G**) Representative negative-stain electron micrographs of purified His~6~-MBP-*Mm* SYCP2^1325-1500^:SYCP3^84-254^. See [Figure 2---figure supplement 5](#fig2s5){ref-type="fig"} for additional full micrographs. (**H**) Schematic summary of negative-stain electron microscopy results: *Mm* SYCP2^1325-1500^:SYCP3^84-248^ forms individual filaments assembled from \~23 nm units, while re-addition of the highly-conserved C-terminal six residues of SYCP3 (249--254; shown in gray below schematic) causes self-association/bundling of these filaments.](elife-40372-fig2){#fig2}

To outline protein-protein interactions within the mammalian chromosome axis, we used yeast two-hybrid assays to test for interactions between SYCP2, SYCP3, and HORMAD2. We identified a short region of SYCP2 directly following the protein's ordered N-terminal domain (residues 395--414) that binds the HORMAD2 HORMA domain in both yeast two-hybrid and when co-expressed in *E. coli* ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2A--C](#fig2s2){ref-type="fig"}). This region shares homology to HORMAD1 and HORMAD2 C-termini, suggesting that it constitutes a closure motif ([Figure 2A](#fig2){ref-type="fig"}, [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). The location of the putative SYCP2 closure motif---directly following the ordered N-terminal domain---is also equivalent to the location of the budding-yeast Red1 closure motif, lending support to the idea that SYCP2 and Red1 are homologs. We directly tested binding of the isolated HORMAD2 HORMA domain (residues 1--241) to a peptide encoding the putative closure motif of HORMAD2, and detected robust binding ([Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}). Further, a pre-assembled complex of HORMAD2 and the putative SYCP2 closure motif showed no binding to the HORMAD2 closure motif peptide, indicating that these sequences compete for binding to the HORMAD2 HORMA domain ([Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}). Finally, despite the overall similarity between HORMAD1 and HORMAD2, we have so far been unable to demonstrate an interaction between SYCP2 and HORMAD1. While this is at least partially due to poor expression and solubility of *M. musculus* HORMAD1 in our assays (not shown), it remains possible that SYCP2 only interacts directly with HORMAD2, while HORMAD1 is recruited by HORMAD2 ([@bib38]) and potentially other chromosome axis components.

Our yeast two-hybrid assays also confirmed that the coiled-coil regions of SYCP2 and SYCP3 associate ([Figure 2B](#fig2){ref-type="fig"}). We next sought to purify an SYCP2:SYCP3 complex, in order to characterize its structure and oligomeric state. We co-expressed the coiled-coil domains of *M. musculus* SYCP2 (residues 1325--1500) and SYCP3 (residues 84--248), and found that the proteins form a stoichiometric complex ([Figure 2C](#fig2){ref-type="fig"}) that, like the Red1 C-terminal domain, forms large assemblies in vitro as judged by size-exclusion chromatography ([Figure 3A,B](#fig3){ref-type="fig"}). Analysis of *Mm* SYCP2^1325-1500^:SYCP3^84-248^ assemblies by negative-stain electron microscopy revealed extended filaments much like those we observed for *Zr* Red1^705-798^ ([Figure 2D](#fig2){ref-type="fig"}, [Figure 2---figure supplement 4A](#fig2s4){ref-type="fig"}). When we visualized the same complex with SYCP2 tagged at its N-terminus with MBP (*Mm* MBP-SYCP2^1325-1500^:SYCP3^84-248^) we observed filaments decorated with regularly-spaced pairs of densities \~5 nm in diameter, equivalent to the expected size of a single \~43 kDa MBP monomer ([Figure 2E](#fig2){ref-type="fig"}, [Figure 2---figure supplement 4B](#fig2s4){ref-type="fig"}). We measured the inter-MBP spacing along SYCP2:SYCP3 filaments, and found an average spacing of 23.1 nm, which closely matches the expected length of an α-helical coiled coil \~175 residues in length ([Figure 2F](#fig2){ref-type="fig"}). These data suggest that the SYCP2:SYCP3 complex forms filaments through end-to-end association of individual α-helical units \~23 nm in length, with each unit containing two copies of SYCP2.

![SYCP2:SYCP3 filaments are assembled from end-to-end interactions of a 2:2 heterotetrameric unit.\
(**A**) Schematic of the predicted coiled-coil regions of *M. musculus* SYCP2 and SYCP3, with truncations used for co-expression/size exclusion chromatography analysis in panels (**B**) and (**C**). (**B**) Superose-6 size exclusion chromatography analysis of truncated *Mm* SYCP2:SYCP3 complexes. All complexes were purified after co-expression using an N-terminal His~6~-MBP tag on SYCP2. *Upper panel:* truncation of the SYCP2 coiled-coil C-terminus, from 1325 to 1500 (black) to 1325--1479 (magenta), all co-expressed with SYCP3^84-248^. *Lower panel:* truncation of SYCP3 coiled-coil N-terminus, from 84 to 248 (black) to 105--248 (green), all co-expressed with SYCP3^1325-1500^. Magenta dotted line indicates elution profile of MBP-SYCP2^1325-1479^:SYCP3^105-248^ complex (*Mm* SYCP2^CC^:SYCP3^CC^), used for SEC-MALS in panel (**C**). *Lower right:* SDS-PAGE analysis of purified *Mm* SYCP2^CC^:SYCP3^CC^ complex (with His~6~-MBP tag removed). (**C**) SEC-MALS analysis of purified His~6~-MBP-*Mm* SYCP2^CC^:SYCP3^CC^ complex. Calculated molecular weight of a 2:2 heterotetramer = 161.4 kDa; Measured molecular weight = 158.6 kDa. (**D**) Thermofluor melting-temperature (*T~m~*) analysis for *Mm* SYCP2^CC^:SYCP3^CC^ (red) versus a homotetrameric *Mm* SYCP3^CC^ complex (green). Thick colored lines represent an average of three independent measurements, with standard deviation represented by thin vertical black lines.](elife-40372-fig3){#fig3}

The experiments above were conducted with a construct of SYCP3, residues 84--248, lacking the C-terminal six residues of this protein. These residues have been previously shown to be critical for formation of large homotypic SYCP3 filaments when the protein is overexpressed in mammalian tissue-culture cells ([@bib3]; [@bib101]), and for formation of large SYCP3 assemblies in vitro ([@bib81]).We next purified an SYCP2:SYCP3 complex containing these residues, *Mm* SYCP2^1325-1500^:SYCP3^84-254^, and visualized the complex by negative-stain electron microscopy. We found that this complex forms filaments equivalent to *Mm* SYCP2^1325-1500^:SYCP3^84-248^, but that in contrast to the truncated complex, filaments containing the full SYCP3 C-terminus tended to self-associate into bundles ([Figure 2G](#fig2){ref-type="fig"}). Given the high conservation of these residues and their importance for large-scale SYCP3 assembly in multiple assays, we propose that the SYCP3 C-terminus may mediate bundling of SYCP2:SYCP3 filaments as an important step in assembly of the mammalian meiotic chromosome axis ([Figure 2H](#fig2){ref-type="fig"}). As we do not observe bundling in filaments of budding-yeast Red1 ([Figure 1C](#fig1){ref-type="fig"}) or plant axis core proteins (see below), this tendency to bundle may be specific to the mammalian chromosome axis.

We next sought to further dissect the SYCP2:SYCP3 filament assembly. We progressively truncated both proteins, and found that removal of 21 residues from either the SYCP2 C-terminus (residues 1480--1500) or the SYCP3 N-terminus (residues 84--104) led to a strong reduction in filament formation, and the appearance of a well-defined smaller complex, as measured by size-exclusion chromatography ([Figure 3A,B](#fig3){ref-type="fig"}). Importantly, these truncations reduced filament assembly while maintaining the association between the two proteins ([Figure 3B](#fig3){ref-type="fig"}). We combined the truncations on both proteins to yield a minimal construct, *Mm* SYCP2^1325-1479^:SYCP3^105-248^, which we term SYCP2^CC^:SYCP3^CC^ hereon. We first measured the molecular weight of the SYCP2^CC^:SYCP3^CC^ complex with an N-terminal MBP tag on SYCP2^CC^ by SEC-MALS. The measured molecular weight of this complex, 159 kDa, closely matched the predicted molecular weight of 161 kDa for a 2:2 heterotetramer of SYCP2 and SYCP3 ([Figure 3C](#fig3){ref-type="fig"}).

Prior work on *H. sapiens* SYCP3 has shown that this protein self-associates to form coiled-coil homoetramers in vitro ([@bib81]). We found that *Mm* SYCP3^CC^ also forms homotetramers in the absence of SYCP2^CC^ (not shown), and when we determined the structure of *Mm* SYCP3^CC^ by x-ray crystallography, we observed an antiparallel coiled-coil homotetramer similar in structure to *H. sapiens* SYCP3 ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). We were unable to determine a structure of the SYCP2^CC^:SYCP3^CC^ heterotetramer. As SYCP2 and SYCP3 share limited sequence homology in their coiled-coil region, we reasoned that SYCP3 homotetramers may form through promiscuous coiled-coil interactions in the absence of SYCP2. To compare the stability of *Mm* SYCP3^CC^ homotetramers with *Mm* SYCP2^CC^:SYCP3^CC^ heterotetramers, we measured their melting temperatures (*T~m~*) using a dye-binding assay. We found that the SYCP2^CC^:SYCP3^CC^ heterotetramer is more stable than SYCP3^CC^ on its own (56.0°C *T~m~* versus 52.5°C; [Figure 3D](#fig3){ref-type="fig"}), supporting the idea that the heterotetrameric complex is the preferred state when both proteins are present.

The SYCP2:SYCP3 complex is an antiparallel heterotetramer {#s2-3}
---------------------------------------------------------

While the SYCP3^CC^ homotetramer is likely not the favored state in the presence of SYCP2, its structure may nonetheless be informative as to the structure of SYCP2^CC^:SYCP3^CC^. Given its 2:2 stoichiometry and our observed effects on filament formation from truncating opposite ends of SYCP2 and SYCP3, we reasoned that SYCP2^CC^:SYCP3^CC^ may form a complex with two SYCP2 protomers oriented parallel to one another, and antiparallel to two SYCP3 protomers. To test this idea, we generated a series of *Hs* and *Mm* SYCP2:SYCP3 constructs with the two proteins fused end-to-end through a short peptide linker ([Figure 4A](#fig4){ref-type="fig"}). One such construct, *Hs* SYCP3^87-230^-\[GSGASG\]-SYCP2^1352-1508^ (termed *Hs* SYCP3^CC^-SYCP2^CC^ fusion hereon), was highly-expressed in *E. coli* and formed a stable dimer by SEC-MALS, equivalent to an SYCP2:SYCP3 heterotetramer ([Figure 4B](#fig4){ref-type="fig"}). We were unable to crystallize this complex, so we turned instead turned to small-angle x-ray scattering, which provides low-resolution size and shape information on macromolecular complexes in solution. SAXS can provide a reliable measure of a particle's maximum dimension (*d~max~*) and radius of gyration (*R~g~*), as well as, for cylindrical particles, the cross-sectional radius of gyration (*R~c~*) ([@bib22]; [@bib27]). Analysis of the *Hs* SYCP3^CC^-SYCP2^CC^ fusion by SAXS showed that this complex's *d~max~*, *R~g~*, and *R~c~* closely match theoretical values calculated from the crystal structure of the *Hs* SYCP3^CC^ homotetramer ([Figure 4C--E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Further, the intra-particle distance distribution function calculated from the SAXS scattering curve also closely matched the profile calculated from the *Hs* SYCP3^CC^ crystal structure ([Figure 4C](#fig4){ref-type="fig"}). We next performed SAXS on the same *Hs* SYCP3^CC^-SYCP2^CC^ fusion containing a \~ 43 kDa MBP tag fused to its N-terminus ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). The measured intra-particle distance distribution of this construct agreed closely to a model containing two MBP monomers at the same end of an SYCP2:SYCP3 tetramer, rather than opposite ends, supporting our model in which the two SYCP3^CC^-SYCP2^CC^ monomers are arranged parallel to one another in the complex. Finally, we also performed SAXS analysis on the heterotetrameric *Mm* SYCP2^CC^:SYCP3^CC^ complex ([Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}). This complex partially aggregated in solution, precluding detailed analysis, but showed results broadly consistent with the *Hs* SYCP3^CC^-SYCP2^CC^ fusion. Overall, these data show that the SYCP2^CC^:SYCP3^CC^ complex forms an extended coiled-coil tetramer with an overall structure similar to that of the SYCP3 homotetramer.

![Structural analysis of the SYCP2:SYCP3 complex.\
(**A**) Design of the *H. sapiens* SYCP3^CC^-SYCP2^CC^ fusion, based on the idea that SYCP2 and SYCP3 helices pack antiparallel in the 2:2 heterotetrameric structure. (**B**) SEC-MALS analysis of purified His~6~-MBP-*Hs* SYCP3^CC^-\[GSGASG\]-SYCP2^CC^. Measured molecular weight (167.7 kDa) is equivalent to the calculated molecular weight of a homodimer (equivalent to a 2:2 heterotetramer of SYCP2 and SYCP3; 163.7 kDa). (**C**) Intra-particle distance distribution (*P*(*r*)) curve for the *Hs* SYCP3^CC^-SYCP2^CC^ fusion construct derived from small-angle x-ray scattering (SAXS) analysis (magenta), compared to the calculated distance distribution of the *Hs* SYCP3^CC^ homotetramer structure (PDB ID 4CPC; dotted black line) ([@bib81]). Lower: table comparing radius of gyration (*R~g~*), cross-sectional radius of gyration (*R~c~*), and maximum dimensions (*d~max~*) of the *Hs* SYCP3^CC^-SYCP2^CC^ fusion (calculated from SAXS; see [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}) and the *Hs* SYCP3^CC^ homotetramer (calculated from the crystal structure). See [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"} for SAXS analysis of *Hs* MBP-SYCP3^CC^-SYCP2^CC^, and [Figure 4---figure supplement 4](#fig4s4){ref-type="fig"} for SAXS analysis of the *Mm* SYCP2^CC^:SYCP3^CC^ complex. (**D**) Structure of the *Hs* SYCP3^CC^ homotetramer structure (PDB ID 4CPC; dotted black line) ([@bib81]), with two parallel chains (N-termini left) colored green, and the other two chains (N-termini right) colored gray. We determined the crystal structure of the *M. musculus* SYCP3^CC^ homotetramer in two different crystal forms ([Figure 4---figure supplement 1A--D](#fig4s1){ref-type="fig"}). This structure resembles the structure of *Hs* SYCP3^CC^ in the central coiled-coil region, but adopts a distinct, more disordered structure near both ends. (**E**) Model of an *Hs* SYCP2^CC^:SYCP3^CC^ 2:2 heterotetramer, with two SYCP3 chains colored green as in panel (D) (N-termini left), and two SYCP2 chains colored magenta (N-termini right). Sequence register was derived from aligning SYCP2 and SYCP3 sequences. (**F**) Schematic of crosslinking mass spectrometry (XLMS) results on the *Hs* SYCP3^CC^-SYCP2^CC^ fusion. Crosslinks observed at least eight times are colored yellow, and crosslinks observed at least 20 times are colored orange. See [Supplementary file 2](#supp2){ref-type="supplementary-material"}--[4](#supp4){ref-type="supplementary-material"} and [Figure 4---figure supplement 5](#fig4s5){ref-type="fig"} for full results. 9 of 10 high-scoring crosslinks support the antiparallel subunit arrangement shown in panel (E).](elife-40372-fig4){#fig4}

Our reconstitution and SAXS analysis of the SYCP3^CC^-SYCP2^CC^ fusion supported a model of the SYCP2:SYCP3 tetramer in which two SYCP2 monomers are arranged parallel to one another, and antiparallel to two SYCP3 monomers. To further confirm this model, we used cross-linking mass spectrometry (XLMS), which identifies pairs of lysine residues whose side-chains are in close proximity in a native complex. We identified 55 cross-links in the *Hs* SYCP3^CC^-SYCP2^CC^ fusion construct: 15 within the SYCP3 region, 13 within SYCP2, and 27 between SYCP3 and SYCP2 ([Supplementary file 2](#supp2){ref-type="supplementary-material"}, [Supplementary file 3](#supp3){ref-type="supplementary-material"}). Of the 27 cross-links identified between SYCP2 and SYCP3, ten were observed at least 8 times in our mass spectrometry experiments. Using sequence alignments and the structures of *H. sapiens* and *M. musculus* SYCP3, we generated physical models for SYCP2:SYCP3 where the monomers are arranged either parallel or antiparallel, and mapped all identified crosslinks onto these models ([Figure 4F](#fig4){ref-type="fig"}, [Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}, [Supplementary file 4](#supp4){ref-type="supplementary-material"}). In agreement with our SAXS data, the crosslinking data strongly support a heterotetramer model with two SYCP2 monomers arranged parallel to one another and antiparallel to two SYCP3 monomers. We propose that these heterotetrameric SYCP2:SYCP3 complexes associate end-to-end to form extended filaments, which can potentially further associate with one another (bundle) through the SYCP3 C-terminus to form the foundation of the chromosome axis.

Plant ASY3 binds HORMADs and forms filaments with ASY4 {#s2-4}
------------------------------------------------------

In higher plants, the chromosome axis comprises meiosis-specific cohesin complexes ([@bib4]; [@bib11]; [@bib41]; [@bib104]); two meiotic HORMAD proteins, ASY1 and ASY2 ([@bib13]): and two coiled-coil proteins, ASY3 and ASY4 ([@bib14]; [@bib24]; [@bib62]). ASY3 is required for axis localization of ASY1, and its disruption causes a strong defect in crossover formation ([@bib24]). Despite low sequence identity with either Red1 or SYCP2, ASY3 has been proposed as a functional homolog of Red1 based on phenotypic similarities plus the presence of a conserved C-terminal domain with predicted coiled-coil character ([Figure 5A](#fig5){ref-type="fig"}) ([@bib24]). ASY4 was recently identified by two groups as a short protein with high homology to the ASY3 coiled-coil domain, that also interacts with ASY3 ([@bib14]; [@bib62]).

![Plant ASY3 and ASY4 share a conserved molecular architecture with mammalian and budding-yeast axis proteins.\
(**A**) Schematic of *Arabidopsis thaliana* chromosome axis proteins, with truncations used for yeast two-hybrid assays shown for ASY1, ASY3, and ASY4. Colored in blue and green are ASY3 constructs that interact with the ASY1 HORMA domain (blue) and ASY4 (green). (**B**) Yeast two-hybrid analysis of *A. thaliana* ASY1, ASY3, and ASY4. AD: Gal4 activation domain fusion; BD: Gal4 DNA-binding domain fusion. Stringent selection on -LEU-TRP-HIS-ADE (-LTHA) media is shown; see [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} for complete results. (**C**) SDS-PAGE analysis of purified His~6~-MBP-tagged closure motifs in ASY3 (residues 2--50) and ASY1 (residues 570--596) in complex with untagged ASY1 HORMA domain (residues 1--234). Complexes were purified using Ni^2+^ affinity and size-exclusion chromatography. (**D**) Sequence alignment of the putative closure motif regions of *At* ASY1 (residues 568--596) and ASY3 (residues 8--35). The two regions show weak homology with a central region enriched in hydrophobic residues, bracketed on both sides by positively-charged residues. See [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"} for sequence alignments of both regions. (**E**) SDS-PAGE analysis of purified His~6~-MBP-ASY3^605-793^:ASY4^FL^ complexes used for negative-stain EM analysis (panel F). (**F**) Representative negative-stain electron micrographs of purified His~6~-MBP-ASY3^605-793^:ASY4^FL^ filaments. See [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"} for additional full micrographs. (**G**) Quantification of inter-MBP spacing in micrographs of His~6~-MBP-*Mm* SYCP2^1325-1500^:SYCP3^84-248^ filaments. The measured spacing of 23.0 ± 2.9 nm (mean ±standard deviation from 41 measured intervals) is equivalent to the length of a \~160 residue coiled-coil (0.146 nm rise per residue). Predicted coiled-coil regions of ASY3 and ASY4 are \~145 and \~180 residues, respectively.](elife-40372-fig5){#fig5}

To define protein-protein interactions within the plant chromosome axis, we used yeast two-hybrid assays to test interactions between *A. thaliana* ASY1, ASY3, and ASY4. We found that the ASY1 N-terminal HORMA domain (residues 1--234) interacts with its own extreme C-terminus (residues 558--596), revealing that this protein possesses a C-terminal closure motif like its orthologs in *C. elegans*, mammals, and fungi ([Figure 5B](#fig5){ref-type="fig"}). We further identified an ASY1 HORMA domain-interacting region at the N-terminus of ASY3 (residues 1--50; [Figure 5B](#fig5){ref-type="fig"}). This region contains a highly-conserved motif of \~30 residues with limited sequence homology to the ASY1 C-terminus ([Figure 5D](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}), suggesting that both regions act as HORMAD-binding closure motifs. To verify these interactions, we co-expressed each putative closure motif (fused to an N-terminal His~6~-MBP tag) with the ASY1 HORMA domain in *E. coli*. Both His~6~-MBP-ASY3^2-50^ and His~6~-MBP-ASY1^570-596^ co-purified with untagged ASY1 HORMA domain through Ni^2+^-affinity and size exclusion chromatography ([Figure 5C](#fig5){ref-type="fig"}), demonstrating a high-affinity interaction. These findings show that plant meiotic HORMADs, like those from fungi and mammals, can interact with closure motif sequences both at their own C-termini and in the N-terminal region of a Red1-like axis core protein.

We next tested interactions between *A. thaliana* ASY3 and ASY4. We found that the C-terminal coiled-coil region of *At* ASY3 (residues 605--793) interacts with ASY4, confirming the recent finding of Osman et al. in *Brassica oleracea* ([@bib62]) and of Chambon et al. in *A. thaliana* ([@bib14]) ([Figure 5B](#fig5){ref-type="fig"}). We next purified a complex between the coiled-coil domains of *A. thaliana* ASY3 and ASY4 ([Figure 5E](#fig5){ref-type="fig"}), which formed large assemblies in solution as measured by size-exclusion chromatography. Negative-stain electron microscopy on purified His~6~-MBP-ASY3^605-793^:ASY4^FL^ assemblies revealed extended filaments equivalent to those observed with both budding-yeast Red1 and mammalian SYCP2:SYCP3 ([Figure 5F](#fig5){ref-type="fig"}). As with the *Mm* MBP-SYCP2^1325-1500^:SYCP3^84-248^ filament, these filaments were decorated at regular intervals with pairs of MBP densities. When we measured the average distance between paired MBP densities along these filaments, we obtained an average spacing of 23.0 ± 2.9 nm, in close agreement with the spacing in SYCP2:SYCP3 filaments and with the predicted length of the ASY3 and ASY4 coiled-coil regions (\~145 and\~180 residues, respectively, corresponding to coiled-coil lengths of \~21.2 and\~26.3 nm; [Figure 5G](#fig5){ref-type="fig"}). These data strongly suggest that ASY3 and ASY4 assemble into 2:2 heterotetramers that associate end-to-end to form extended filaments, in a manner equivalent to both mammalian SYCP2:SYCP3 and fungal Red1.

Discussion {#s3}
==========

The meiotic chromosome axis plays several crucial roles to support inter-homolog crossover formation and signaling in meiosis I. The first major role is to provide a scaffold for organization of each chromosome as a linear array of loops, with these loops directly extruded or otherwise constrained by cohesin complexes ([@bib106]). The axis assembles in early meiotic prophase, when chromosomes just become visible as the 'thin threads' for which the leptotene stage is named. As cells progress through zygotene and then pachytene ('thick threads'), chromosomes undergo significant linear compaction without disruption of the underlying chromosome axis structure. We have shown here that budding-yeast Red1, mammalian SYCP2:SYCP3, and plant ASY3:ASY4 all form filaments from homo- or hetero-tetrameric units, and that the SYCP2:SYCP3 filaments have a tendency to form bundles. We propose that individual short filaments of these 'axis core proteins' associate loosely with cohesin complexes, then form bundles to assemble a flexible scaffold for cohesin-mediated extrusion/constraint of chromatin loops ([Figure 6](#fig6){ref-type="fig"}). In this scheme, both filament formation by axis core proteins and cohesin activity are required for axis assembly and chromosome compaction, explaining how mutation of axis core proteins like SYCP3 ([@bib57]; [@bib102]; [@bib103]) or cohesin subunits including SMC1β ([@bib57]; [@bib67]), REC8 ([@bib99]), RAD21L ([@bib92]), and STAG3 ([@bib26]; [@bib33]; [@bib92]; [@bib95]) can affect the overall length of the axis. An axis constructed from a flexible core of loosely-associated filaments would also enable axis extension or compression in processes like synaptic adjustment, in which the lengths of two chromosomes can adjust to one another as the synaptonemal complex (SC) assembles between them ([@bib106]).

![The conserved molecular architecture of the meiotic chromosome axis.\
(**A**) Model for assembly of the meiotic chromosome axis in fungi, plants, and mammals. Related axis core proteins (fungal Red1, plant ASY3:ASY4, mammalian SYCP2:SYCP3) form filaments from coiled-coil homo- or heterotetrameric units, which flexibly associate with chromosome-associated cohesin complexes. Chromatin loop extrusion by cohesin complexes and bundling of axis-core filaments leads to formation of the chromosome axis, which is flexible and able to axially compress or expand if needed. (**B**) List of homologous chromosome axis proteins in different eukaryotic groups.](elife-40372-fig6){#fig6}

A second critical function of the chromosome axis is to promote the formation of meiotic DSBs, then orchestrate the repair of a subset of DSBs as inter-homolog crossovers. In most organisms, the meiotic HORMADs are major regulators of both DSB formation and crossover formation. We have previously proposed an overall axis assembly pathway in *S. cerevisiae* with cohesin-associated Red1 recruiting Hop1 through its closure motif ([@bib93]), and we can now extend this model to both mammals and plants. We propose that a key conserved function of the axis core proteins is to recruit meiotic HORMADs through their HORMA domain-binding closure motifs. These localized HORMADs may then recruit additional HORMADs through head-to-tail oligomer formation through their own C-terminal closure motifs. Finally, as cells enter pachytene and the axis core proteins become integrated into the SC, HORMADs are removed from the axis by the Pch2/TRIP13 ATPase, thereby suppressing further DSB formation and licensing the progression of meiosis ([@bib7]; [@bib35]; [@bib69]; [@bib76]; [@bib96]).

Importantly, while we show that HORMAD recruitment by axis core proteins is conserved across fungi, mammals, and plants, additional architectural complexity likely exists in organisms with multiple HORMAD proteins. For example, mammalian HORMAD1 and HORMAD2 play distinct roles in meiotic regulation, and may also have distinct recruitment mechanisms: we have demonstrated an interaction between SYCP2 and HORMAD2, but not HORMAD1, leaving open the possibility that HORMAD1 is recruited by other means. In plants, the two HORMAD proteins ASY1 and ASY2 may similarly possess distinct recruitment mechanisms to drive differential biological functions. Further work outlining the specific recruitment mechanisms of individual HORMADs, including their potential dependence on one another through head-to-tail oligomer assembly, will be required to fully understand chromosome axis architecture and function in these organisms.

The third major function of the meiotic axis is to serve as the lateral elements of the SC in pachytene, after the bulk of meiotic HORMADs have been removed. Our physical model of the mammalian chromosome axis, comprising a bundle of SYCP2:SYCP3 filaments with a periodicity of 23 nm, generally agrees with prior electron microscopy (EM) studies showing \~20 nm periodicity in the lateral elements of assembled SCs ([@bib61]). Also in agreement with this model, a recent analysis of mouse SC structure by super-resolution light microscopy has shown that SYCP3 and the SYCP2 coiled-coil region perfectly co-localize in a single 'cable' in each lateral element, and that the C-terminus of the transverse filament protein SYCP1 is situated close to this cable ([@bib74]). Significant questions remain regarding how the SC lateral elements and transverse filaments might interact, and the role of cohesin complexes in this interaction is also unknown. Recently, it was reported that REC8 and RAD21L, meiosis-specific cohesin complex kleisin subunits, both localize slightly 'inside' SYCP3; that is, they are situated closer to the SYCP1 transverse filaments than the SYCP2:SYCP3 complex ([@bib70]). These data suggest that cohesin complexes may somehow be integrated into the structure of the SC, in a manner that is not yet well-understood.

Several recent studies have reported that in vitro, mammalian SYCP3 forms coiled-coil homotetramers that further assemble into large oligomeric structures with a 22 nm periodicity ([@bib81]). Further, SYCP3 can bind DNA through two short patches of basic residues near the N-terminus of this protein's coiled-coil domain ([@bib81]), and large SYCP3 oligomers appear to bind and condense plasmid DNA ([@bib6]). These data have led to a model whereby homotypic SYCP3 oligomers, interacting directly with DNA, form a major part of the mammalian chromosome axis ([@bib81]). While we cannot rule out the formation of homotypic SYCP3 assemblies in meiotic cells, our data shows that the SYCP2:SYCP3 heterotetramer is more stable in solution than the SYCP3 homotetramer, and is therefore likely to be the preferred assembly in meiotic cells. Further, as SYCP3 does not localize to the chromosome axis in a mutant of SYCP2 lacking its coiled-coil domain ([@bib100]), direct SYCP3-DNA binding is unlikely to contribute significantly to axis formation.

We have shown that the architecture of the meiotic chromosome axis is highly conserved across fungi, mammals, and plants. Our model assigns critical functions in both overall axis structure and HORMAD recruitment to the axis core proteins, yet some organisms, including *C. elegans* and *D. melanogaster*, appear to lack axis core proteins entirely. Our prior work has strongly suggested that the meiotic HORMADs in *C. elegans* interact directly with cohesin complexes ([@bib38]), and thus far meiotic HORMADs have not been identified in *D. melanogaster*. We propose that the key feature of meiosis in both *C. elegans* and *D. melanogaster* that eliminates the need for axis core proteins is that these organisms assemble the SC prior to meiotic recombination. Thus, the SC itself can provide a physical scaffold for chromosome organization and recombination control in these organisms, eliminating much of the need for a distinct chromosome axis that assembles prior to SC formation.

While our data shed significant new light on the assembly and function of the meiotic chromosome axis, significant questions remain. First, while the N-terminal domains of both Red1 and SYCP2 likely adopt similar structures and mediate these proteins' association with meiotic chromosomes, their direct binding partners are as yet mysterious. A recent study identified several potential binding partners of the SYCP2 N-terminal domain ([@bib23]), but as these proteins are mostly centromere-associated, it remains unknown what SYCP2 may bind along the length of chromosomes. We propose that the SYCP2 and Red1 N-terminal domains may bind cohesin complexes directly ([@bib79]), or may instead bind one or more chromatin-associated proteins, perhaps even a specific histone mark, to mediate a flexible interaction with chromatin.

A further mystery involves plant ASY3, which appears to entirely lack a Red1/SYCP2-like N-terminal domain. This protein may associate with chromosome-localized proteins through one or more short conserved motifs in its extended disordered region, or may in fact be recruited through interactions with the HORMADs ASY1 and ASY2. Both plant ASY1 and fungal Hop1 possess putative DNA- or protein-binding domains in their central regions, raising the possibility that these meiotic HORMADs could recruit axis core proteins to meiotic chromosomes, in a reversal of the canonical localization-dependence of these proteins. Thus, while the overall theme of axis assembly through filament formation is likely conserved across many eukaryotic families, each family appears to have evolved variations on this theme in keeping with its own unique requirements.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                 Designation                                 Source or reference                                                                                               Identifiers       Additional\
  or resource                                                                                                                                                                                                                   information
  --------------------------------------------- ------------------------------------------- ----------------------------------------------------------------------------------------------------------------- ----------------- ------------------------------------
  Strain, strain background (*S. cerevisiae*)   strain AH109                                Clontech                                                                                                                            

  Strain, strain background (*S. cerevisiae*)   strain Y187                                 Clontech                                                                                                                            

  Strain, strain background (*E. coli*)         Rosetta2 (DE3) pLysS                        Novagen                                                                                                                             

  Genetic reagent (*S. cerevisiae*)             S288c genomic DNA                           Invitrogen                                                                                                        cat. \# 69240     

  Genetic reagent\                              NRRL Y-229 genomic DNA                      ATCC                                                                                                              cat. \# 2623D-5   
  (*Z. rouxii*)                                                                                                                                                                                                                 

  Genetic reagent (*M. musculus*)               HORMAD1 cDNA                                TransOMIC Technologies                                                                                            BC051129          

  Genetic reagent (*M. musculus*)               HORMAD2\                                    TransOMIC\                                                                                                        BC120781          
                                                cDNA                                        Technologies                                                                                                                        

  Genetic reagent (*M. musculus*)               SYCP2 cDNA                                  Harvard PlasmID                                                                                                   MmCD0083242       

  Genetic reagent (*M. musculus*)               SYCP3                                       GeneArt                                                                                                                             Synthesized gene fragment

  Genetic reagent (*H. sapiens*)                SYCP2                                       GeneArt                                                                                                                             Synthesized\
                                                                                                                                                                                                                                gene fragment

  Genetic\                                      SYCP3                                       GeneArt                                                                                                                             Synthesized gene fragment
  reagent (*H. sapiens*)                                                                                                                                                                                                        

  Genetic\                                      ASY1                                        GeneArt                                                                                                                             Synthesized gene fragment
  reagent (*A. thaliana*)                                                                                                                                                                                                       

  Genetic reagent (*A. thaliana*)               ASY3                                        GeneArt                                                                                                                             Synthesized\
                                                                                                                                                                                                                                gene fragment

  Genetic reagent\                              ASY4                                        GeneArt                                                                                                                             Synthesized\
  (*A. thaliana*)                                                                                                                                                                                                               gene fragment

  Antibody                                      Rabbit polyclonal Anti-Red1 antibody (1)    Gift from\                                                                                                                          used for\
                                                                                            G. S. Roeder                                                                                                                        immunofluorescence

  Antibody                                      Rabbit polyclonal Anti-Red1\                Gift from N. Hollingsworth                                                                                                          used for Western\
                                                antibody (2)                                                                                                                                                                    blotting

  Antibody                                      Mouse polyclonal Anti-Gmc2 antibody         Prosci Inc.                                                                                                                         used for immunofluorescence

  Antibody                                      Goat polyclonal anti-rabbit HRP antibody    Jackson Immunoresearch                                                                                            111-035-003       used for Western blotting

  Recombinant DNA reagent                       Plasmid pGADT7                              Clontech                                                                                                                            

  Recombinant DNA reagent                       Plasmid pBridge                             Clontech                                                                                                                            

  Recombinant DNA reagent                       Macrolab vector 2CT                         UC Berkeley Macrolab                                                                                                                

  Recombinant DNA reagent                       Macrolab vector 13S-A                       UC Berkeley Macrolab                                                                                                                

  Recombinant DNA reagent                       Macrolab vector 2 ST                        UC Berkeley Macrolab                                                                                                                

  Peptide,\                                     TEV protease                                David Waugh, National Cancer Institute                                                                            Clone pRK793      Purified in-house
  recombinant protein                                                                                                                                                                                                           

  Peptide,\                                     Mm HORMAD2\                                 Biomatik, Inc.                                                                                                                      Sequence:\
  recombinant protein                           closure motif\                                                                                                                                                                  FITC-Ahx-EPSFESSRKKKKVSEPVTVFIPNRK
                                                peptide                                                                                                                                                                         

  Commercial assay or kit                       HisTrap HP column                           GE Life Sciences                                                                                                                    

  Commercial assay or kit                       HiTrap Q HP column                          GE Life Sciences                                                                                                                    

  Commercial assay or kit                       Superdex 200 column                         GE Life Sciences                                                                                                                    

  Chemical compound, drug                       D0/D12 BS3 (bis-sulfosuccinimidylsuberate   Creative Biomolecules                                                                                             cat. \# BS3       

  Software, algorithm                           RAPD                                        <https://github.com/RAPD>                                                                                                           

  Software, algorithm                           AIMLESS                                     <http://www.ccp4.ac.uk>                                                                                                             

  Software, algorithm                           TRUNCATE                                    <http://www.ccp4.ac.uk>                                                                                                             

  Software, algorithm                           autoxds                                     Stanford Synchrotron Radiation Lightsource                                                                                          In-house script

  Software,\                                    ARCIMBOLDO                                  <http://chango.ibmb.csic.es>                                                                                                        
  algorithm                                                                                                                                                                                                                     

  Software, algorithm                           PHENIX                                      <http://www.phenix-online.org/download/>                                                                                            

  Software, algorithm                           PHASER                                      <http://www.phaser.cimr.cam.ac.uk/index.php/Phaser_Crystallographic_Software>                                                       

  Software, algorithm                           RESOLVE                                     <https://solve.lanl.gov>                                                                                                            

  Software, algorithm                           COOT                                        [https://www2.mrc-lmb.cam.ac. uk/personal/pemsley/coot/](https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/)                     

  Software, algorithm                           ATSAS                                       <https://www.embl-hamburg.de/biosaxs/software.html>                                                                                 SAXS analysis suite

  Software,\                                    xQuest                                      <http://prottools.ethz.ch/orinner/public/htdocs/xquest/>                                                                            
  algorithm                                                                                                                                                                                                                     

  Software,\                                    Graphpad Prism                              Graphpad software - <https://www.graphpad.com>                                                                    version 7         
  algorithm                                                                                                                                                                                                                     
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Cloning and protein purification {#s4-1}
--------------------------------

### Mammalian proteins {#s4-1-1}

For yeast two-hybrid analysis, *M. musculus* genes were PCR-amplified from cDNA (SYCP2: Harvard PlasmID clone MmCD00083242; HORMAD1: TransOMIC technologies clone BC051129; HORMAD2: TransOMIC technologies clone BC120781) or synthesized DNA fragment (SYCP3; GeneArt) and inserted by ligation-independent cloning into modified pBridge and pGADT7 vectors (Clontech). For co-expression, *M. musculus* SYCP2 and SYCP3 fragments were separately cloned into UC Berkeley Macrolab vectors 2CT (SYCP2; Amp^R^, N-terminal His~6~-MBP fusion) or 13S-A (SYCP3; Spec^R^, no tag) by ligation-independent cloning. For expression of SYCP3 alone, *M. musculus* SYCP3^105-248^ was cloned into UC Berkeley Macrolab vector 2 ST (N-terminal His~6~-SUMO fusion). The *H. sapiens* SYCP2-SYCP3 fusion construct was assembled by multi-part PCR from synthesized-fragment templates (GeneArt) and inserted into vector 2CT by ligation-independent cloning. For co-expression of *M. musculus* SYCP2:HORMAD2 complexes, a polycistronic expression cassette was assembled by PCR and inserted into vector 2CT, yielding a final vector encoding His~6~-MBP-tagged SYCP2 fragments plus untagged HORMAD2^1-241^.

For purification of SYCP2:SYCP3 complexes, His~6~-MBP-SYCP2 and SYCP3 constructs were co-transformed into *E. coli* strain Rosetta 2(DE3) pLysS (Novagen), and grown in the presence of ampicillin, spectinomycin and chloramphenical to an OD~600~ of 0.9 at 37°C, induced with 0.25 mM IPTG, then grown for a further 16 hr at 18°C prior to harvesting by centrifugation. For purification, cells were lysed by sonication, then clarified lysates were purified by Ni^2+^ affinity (HisTrap HP; GE Life Sciences), ion exchange (HiTrap SP or Q; GE Life Sciences), and size exclusion chromatography (Superdex 200; GE Life Sciences). *H. sapiens* SYCP2:HORMAD2 complexes were coexpressed as above, then purified by Ni^2+^ affinity chromatography and analyzed by SDS-PAGE. In cases where cleavage of N-terminal His~6~-MBP or His~6~-SUMO tags was required, tags were removed by incubation with TEV protease at 4°C for 16 hr, then the mixture was passed over a Ni^2+^ affinity column, and the flow-through fractions were concentrated and purified by size-exclusion chromatography.

For size-exclusion chromatography-based assays of SYCP2:SYCP3 filament formation, His~6~-MBP-SYCP2:SYCP3 complexes were initially purified by Ni-NTA chromatography, then passed over a Superose-6 size-exclusion column (GE Life Sciences) to remove small-molecular weight contaminants. Fractions corresponding to the entire range containing SYCP2:SYCP3 complexes were pooled, concentrated, then passed over Superose-6 a second time for the traces shown in [Figure 3B](#fig3){ref-type="fig"}. N-terminal His~6~-MBP tags were not removed for this analysis.

For size exclusion chromatography coupled to multi-angle light scattering (SEC-MALS), 100 μL purified proteins at 2--5 mg/mL was injected onto a Superdex 200 Increase 10/300 GL column (GE Life Sciences) in a buffer containing 20 mM HEPES pH 7.5, 300 mM NaCl, 5% glycerol, and 1 mM DTT. Light scattering and refractive index profiles were collected by miniDAWN TREOS and Optilab T-rEX detectors (Wyatt Technology), respectively, and molecular weight was calculated using ASTRA v. six software (Wyatt Technology).

### Fungal proteins {#s4-1-2}

*Zygosaccharomyces rouxii* Red1 constructs were amplified by PCR and inserted by ligation-independent cloning into UC Berkeley Macrolab vector 2CT (Amp^R^, N-terminal His~6~-MBP fusion) for expression in *E. coli*. Proteins were expressed and purified as above.

### Plant proteins {#s4-1-3}

Full-length codon-optimized genes for *Arabidopsis thaliana* ASY1, ASY3, and ASY4 were synthesized (GeneArt) and inserted by ligation-independent cloning into modified pBridge and pGADT7 vectors (Clontech) for yeast two-hybrid analysis, or cloned into UC Berkeley Macrolab vectors 2CT/13S-A for expression in *E. coli*. Truncations were amplified by PCR and similarly cloned.

For co-purification of the ASY1 HORMA domain with putative closure motif peptides, putative closure motifs (ASY3^2-50^ and ASY1^570-596^) in vector 2CT (N-terminal His~6~-MBP fusion) and ASY1^1-234^ in vector 13S-A (untagged) were co-transformed into *E. coli* strain Rosetta 2(DE3) pLysS, and grown in the presence of ampicillin, spectinomycin and chloramphenical to an OD~600~ of 0.9 at 37°C, induced with 0.25 mM IPTG, then grown for a further 16 hr at 18°C prior to harvesting by centrifugation. For purification, cells were lysed by sonication, then clarified lysates were purified by Ni^2+^ affinity (HisTrap HP; GE Life Sciences) and size exclusion chromatography (Superdex 200; GE Life Sciences). For purification of ASY3:ASY4 for electron microscopy, ASY3^605-793^ in vector 2CT (N-terminal His~6~-MBP fusion) and full-length ASY4 in vector 13S-A (untagged) were co-transformed into *E. coli* strain Rosetta 2(DE3) pLysS, and grown in the presence of ampicillin, spectinomycin and chloramphenical to an OD~600~ of 0.9 at 37°C, induced with 0.25 mM IPTG, then grown for a further 16 hr at 18°C prior to harvesting by centrifugation, and purified as above.

Yeast two-hybrid {#s4-2}
----------------

For yeast two-hybrid analysis, plasmids were transformed into AH109 and Y187 yeast strains (Clontech), and transformants were selected using CSM -Leu (for pGADT7 vectors) and CSM -Trp (pBridge vectors) media. Haploid yeast strains were mated overnight at room temperature, and diploids were selected using CSM -Leu-Trp media. Diploids were patched onto low-stringency (CSM -Leu-Trp-His) and high stringency media (CSM -Trp-Leu-His-Ade), grown for 1--3 days at 30°C, and imaged.

Fluorescence polarization {#s4-3}
-------------------------

An N-terminal FITC-Ahx labeled *Mm* HORMAD2^288-306^ peptide was synthesized (BioMatik), resuspended in DMSO, then diluted into binding buffer (20 mM Tris pH 7.5, 300 mM NaCl, 10% glycerol, 1 mM DTT, 0.1% NP-40). Fifty μL reactions containing 50 nM peptide plus up to 50 μM bait proteins were incubated 60 min at room temperature, then fluorescence polarization was read in 384-well plates using a TECAN Infinite M1000 PRO fluorescence plate reader. All binding curves were done in triplicate. Binding data were analyzed with Graphpad Prism v. seven using a single-site binding model.

Electron microscopy {#s4-4}
-------------------

For negative-stain electron microscopy, protein complexes were passed over a size exclusion column (Superdex 200 Increase 10/300 GL; GE Life Sciences) in EM buffer (300 mM NaCl, 20 mM Tris-HCl pH 7.5, 1 mM DTT), and peak fractions were diluted to \~0.01 mg/mL in EM buffer. Samples were spotted on freshly glow-discharged carbon coated copper grids, blotted into a thin film, and stained using 2% of uranyl formate. Electron micrographs were acquired on a Tecnai F20 Twin transmission electron microscope (FEI, Hillsboro OR) operating at 200 kV on a Tietz F416 4K × 4K CMOS camera (TVIPS, Gauting, Germany). For untagged *Zr* Red1^705-798^ and MBP-ASY3^605-793^:ASY4^FL^, micrographs were acquired on a FEI Talos F200C with 4K × 4K CMOS camera (Thermo Fisher Scientific). Micrographs of His~6~-MBP-SYCP2^1325-1500^:SYCP3^84-248^ and MBP-ASY3^605-793^:ASY4^FL^ were analyzed using ImageJ to determine the average spacing of MBP densities on the respective filaments.

Thermofluor melting assays {#s4-5}
--------------------------

For measurement of melting temperature, 45 uL 0.1 mg/mL purified protein in gel-filtration buffer (20 mM Tris-HCl pH 7.5, 300 mM NaCl, 10% glycerol, 1 mM DTT) was mixed with 5 uL 50X SYPRO orange dye (Life Technologies; 5X final concentration) and pipetted into an optically-clear qPCR plate. SYPRO fluorescence was measured in a Bio-Rad CFX96 qPCR machine in FRET mode (excitation 450--490 nm, emission 560--580) using a temperature range 25--95°C in 0.5° steps (15 s hold per step). Triplicate measurements were averaged, buffer-subtracted, then the derivative of the fluorescence was calculated. The maximum value of the derivative curve (highest rate of change in fluorescence) is assigned as the *T~m~*. N-terminal His~6~-MBP and His~6~-SUMO on SYCP2^1325-1479^:SYCP3^105-248^ and SYCP3^105-248^, respectively, were removed prior to Tm analysis.

Crystallization and structure determination of *M. musculus* SYCP3 homotetramer {#s4-6}
-------------------------------------------------------------------------------

When co-expressed in *E. coli*, *M. musculus* SYCP3 is expressed at much higher levels than SYCP2 (not shown). We found that while *M. musculus* SYCP2^CC^ is insoluble when expressed without SYCP3^CC^, SYCP3^CC^ is able to form soluble homotetramers. While optimizing expression constructs, we co-expressed *M. musculus* His~6~-SUMO-SYCP3^105-248^ with untagged SYCP2^1325-1472^, purified the resulting complex, and identified crystallization conditions. Crystals were obtained in hanging drop format by mixing protein (50--80 mg/mL) with two parts well solution containing 100 mM Tris-HCl pH 8.5, 16% PEG 4000, and 100--200 mM sodium acetate. Later analysis showed that these crystals contain SYCP3 homotetrameric complexes, rather than SYCP2:SYCP3 heterotetramers. Because of the tendency of SYCP3^CC^ to form homotetrameric complexes, all other analysis with SYCP2^CC^:SYCP3^CC^ complexes was performed with complexes expressed with tagged SYCP2 and untagged SYCP3.

SYCP3 homotetramer crystals were cryoprotected by the addition of 20% sucrose, then diffraction data was collected at the Advanced Photon Source, beamline 24ID-C. Despite identical growth conditions and similar shape, crystals belonged to two different space groups (P1 and P2~1~; [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Data collected at the Advanced Photon Source were indexed and scaled by RAPD (<https://github.com/RAPD>), which used XDS ([@bib36]) for indexing and data reduction, and the CCP4 programs AIMLESS ([@bib21]) and TRUNCATE ([@bib94]) for scaling and conversion to structure factors. Data collected at the Stanford Synchrotron Radiation Lightsource was indexed and scaled by the *autoxds* script, which uses XDS, AIMLESS, and TRUNCATE as above. An initial model was determined by ARCIMBOLDO_LITE ([@bib72]) in its COILED_COIL mode ([@bib9]) using a merged P2~1~ dataset assembled from three individual datasets from different crystals, cut to a final resolution of 2.5 Å. ARCIMBOLDO ([@bib52]) uses PHASER ([@bib51]) to place individual α-helices by eLLG (expected log likelihood-gain)-guided molecular replacement ([@bib58]), then expand partial solutions with SHELXE ([@bib86]) through density modification and autotracing into a complete model ([@bib85]). Phases from the initial ARCIMBOLDO model (393 residues) were used to identify selenomethionine sites, which were then supplied to the Phenix Autosol module ([@bib84]) for phase calculation in PHASER ([@bib51]; [@bib66]), density modification including two-fold NCS averaging in RESOLVE ([@bib83]), and initial model building in RESOLVE. Initial models from ARCIMBOLDO and RESOLVE were manually rebuilt in COOT and refined in phenix.refine ([@bib1]) against a single 2.5 Å-resolution dataset collected from crystals of selenomethionine-substituted protein. The register of all four protein chains in the final model, and their identity as SYCP3^CC^, were verified by anomalous difference maps showing the location of selenomethionine residues. While ARCIMBOLDO successfully determined the structure in the P1 crystal form, the initial P1 model used for rebuilding and refinement was generated by molecular replacement in PHASER using the P2~1~ model. The P1 model was refined against a 2.2 Å-resolution dataset generated by merging five independent datasets collected at APS beamline 24ID-E and SSRL beamline 14--1.

### Support statement - Advanced Photon Source NE-CAT beamline 24ID-C {#s4-6-1}

This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403). The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.

### Support statement - Stanford Synchrotron Radiation Lightsource beamline 14--1 {#s4-6-2}

Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.

Small-angle X-ray scattering (SAXS) {#s4-7}
-----------------------------------

For SAXS, *Mm* SYCP2^CC^:SYCP3^CC^ was diluted to 1, 3, or 6 mg/mL in a buffer containing 20 mM Tris-HCl pH 8.5, 300 mM NaCl, 2% glycerol, and 1 mM DTT. Both His~6~-MBP-tagged and untagged *Hs* SYCP3^CC^-SYCP2^CC^ fusion was diluted to 2, 4 or 8 mg/mL in a buffer containing 20 mM Tris-HCl pH 7.5, 300 mM NaCl, 2% glycerol, and 1 mM DTT. SAXS data were collected at the SIBYLS Beamline 12.3.1 at the Advanced Light Source, Lawrence Berkeley National Lab (which is funded by DOE BER Integrated Diffraction Analysis Technologies (IDAT) program and NIGMS grant P30 GM124169-01, ALS-ENABLE) ([@bib19]). For each sample, thirty 0.3 s exposures were taken and integrated, for a total exposure time of 10 s. Exposures were radially averaged and buffer-subtracted to yield SAXS scattering curves. SAXS data analysis was performed with ScÅtter (<https://bl1231.als.lbl.gov/scatter/>) and the ATSAS SAXS analysis suite (<https://www.embl-hamburg.de/biosaxs/software.html>) ([@bib19]).

Crosslinking mass spectrometry (XLMS) {#s4-8}
-------------------------------------

For cross-linking of *Hs* SYCP3^CC^-SYCP2^CC^, the protein was diluted to 1 mg/mL in a buffer containing 20 mM HEPES pH 7.5, 300 mM NaCl, 10% glycerol, and 1 mM DTT. Crosslinking was performed by addition of 0.2, 0.5, or 1 mM isotopically-coded D~0~/D~12~ BS^3^ (bis-sulfosuccinimidylsuberate; Creative Molecules) for 60 min at room temperature. The reaction was quenched by the addition of 100 mM NH~4~HCO~3~ and further incubation at 30°C for 10 min. Quenched reactions were supplemented with 8M urea to a final concentration of 6M. Subsequent to reduction and alkylation, crosslinked proteins were digested with Lys-C (1:50 w/w, Wako) for 3 hr, diluted with 50 mM ammonium bicarbonate to 1M urea and digested with trypsin (1:50 w/w, Promega) overnight. Crosslinked peptides were purified by reversed phase chromatography using C18 cartridges (Sep-Pak, Waters). Crosslink fractions by peptide size exclusion chromatography and analyzed by tandem mass spectrometry (Orbitrap Elite, Thermo Scientific) ([@bib28]). Fragment ion spectra were searched and crosslinks identified by the dedicated software program xQuest ([@bib91]). All unique detected crosslinks are listed in [Supplementary file 2](#supp2){ref-type="supplementary-material"} and [Supplementary file 3](#supp3){ref-type="supplementary-material"}.

Yeast genetics and imaging {#s4-9}
--------------------------

All yeast strains were derived from the SK1-related diploid strain NH144 ([Supplementary file 5](#supp5){ref-type="supplementary-material"}) ([@bib17]; [@bib30]). For *Sc-Zr* Red1 chimeras, a homologous recombination template was generated to replace residues 734--827 with residues 705--798 (wild-type or I715R) or 705--791 of *Zr* Red1, followed by a *KanMX* selection marker, and integrated into the *RED1* locus. For spore viability, cells were grown on YPD agar, patched onto SPO medium (1% KOAc) for 48--72 hr, then tetrads were dissected onto YPD agar and grown 3 days for analysis. Spore viability was 95.3% (122 viable spores out of 128) for *RED1*, 54% for *red1-Sc*^1-734^:*Zr*^707-798^ (28 viable out of 52), 2% for *red1-Sc*^1-734^:*Zr*^707-791^ (1 viable out of 56), and 9.4% for *red1-Sc*^1-734^:*Zr*^707-798^I715R\] (12 viable out of 128).

For synchronous meiosis and fluorescence imaging, cells were sporulated as in ([@bib78]). Briefly, cells were grown in YPD, then diluted into BYTA (BYTA; 50 mM sodium phthalate-buffered, 1% yeast extract, 2% tryptone and 1% acetate) at OD~600~ = 0.3, grown overnight, then washed and resuspended in SPO medium (0.3% KOAc pH 7.0) at OD~600~ = 2.0 at 30° C to induce sporulation. Samples were removed at 3 and 5 hr after transfer to SPO medium, then meiotic nuclei were surface-spread on glass slides and fixed as previously described ([@bib90]), then imaging was carried out using a Deltavision RT Imaging System (Applied Precision) adapted to an Olympus (IX71) microscope. Cells were stained with DAPI, anti-Red1, and anti-Gmc2. Polyclonal mouse anti-Gmc2 antibodies were raised against purified Gmc2 protein (ProSci Inc.); this antibody was used at 1:800 dilution. Polyclonal rabbit anti-Red1 (a kind gift from GS Roeder, [@bib76]) was used at 1:100 dilution. Secondary antibodies conjugated with Alexa Fluor dyes were purchased from Jackson ImmunoResearch and used at 1:200 dilution. For quantification of Red1 and Gmc2 spatial distribution on meiotic chromosomes, 30--50 nuclei were manually scored per condition.

For western blotting, we used primary rabbit anti-Red1 (a kind gift from Nancy Hollingsworth) at 1:10,000 dilution, and secondary goat anti-rabbit HRP (Jackson Immunoresearch) at 1--10,000 dilution.
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Data availability {#s7}
-----------------

Primary diffraction data for *M. musculus* SYCP3 tetramer structures have been deposited with the SBGrid Data Bank (<https://data.sbgrid.org>) under dataset numbers 583 (P21 crystal form) and 584 (P1 form). Reduced diffraction data and refined structural models have been deposited with the Protein Data Bank ([www.pdb.org](http://www.pdb.org)) under accession numbers 6DD8 (P21 crystal form) and 6DD9 (P1 form)

The following datasets were generated:

RosenbergSCMunozIC2018Structure of mouse SYCP3, P21 formProtein Data Bank6DD8

RosenbergSC2018Structure of mouse SYCP3, P1 formProtein Data Bank6DD9

RosenbergSCCorbettKD2019X-Ray Diffraction data from M. musculus SYCP3 residues 105-248, source of 6DD8 structureSBGrid Data Bank583

RosenbergSCCorbettKD2019X-Ray Diffraction data from M. musculus SYCP3 residues 105-248, source of 6DD9 structureSBGrid Data Bank584
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Reviewing Editor

Institute of Human Genetics, CNRS UPR 1142

France

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"A conserved mechanism for meiotic chromosome organization through self-assembly of a filamentous chromosome axis core\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Bernard de Massy as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Jessica Tyler as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary

Meiotic chromosomes have a unique mode of organization with a differentiated axial structure which provides ways to anchor chromatin loops and which is extremely important for the control of all events taking place from prophase to metaphase and thus to ensure the proper segregation of chromosomes at the first meiotic division. Many components are known but the understanding of their molecular organization is still limited. The Corbett group has previously reported the important role and organization of Horma-domain proteins and specifically one motif called the closure motif that provides interaction to itself but also to other partners allowing to build multiprotein complexes as shown in *C. elegans*. This family of Horma-domain proteins is evolutionarily conserved. Using a range of biochemical and structural assays, proteomics and EM the authors show that the assembly mechanism of these axis core proteins and their interaction with other components of the meiotic chromosome axis is conserved in yeast, plants and mammals.

Overall the studies are well conducted and the data is clearly presented. Although some insights are speculative (see below), this work represents a potentially significant advance in understanding the role of axis core proteins in the formation and function of meiotic chromosome structure.

Essential revisions

Several experiments require clarification and further validations. In addition, some conclusions are highly speculative which is fine for a discussion but should not be presented as conclusions of this study per se and thus should not be included in the Abstract or title. Both title and Abstract should highlight the conclusions of the experiments and should be revised. It does not seem that the mechanism of meiotic chromosome organization is known yet: how filaments and bundles form or dissociate is unknown. How cohesins are build-in to contribute to loop formation is also unknown.

1\) Red1 filaments and their role in vivo: the use and test of the chimeric protein (*Sc/Zr*) is important but a critical test that should be done is to mutate the I715 residue in the chimera.

Figure 1H: Please include *Sc* Red1 wild-type staining for comparison and quantify Red1 staining to support the statement that the construct \"does not affect chromosome localization\" (Figure 1H legend).

Does *Sc* Red1 I743A (or I743R) load onto chromosome axes as expected? The yeast imaging is only partially convincing. Protocols are available to actually see the Red1 axis by spreading nuclei which would be much more informative about the consequence of the mutations tested.

2\) Clarify how the closure motif is defined and what experiment beyond the interaction data allows for the conclusion of the presence of a closure motif. In Figure 2A: show the sequence alignment of HORMAD-binding closure motifs of SYCP2, HORMAD1 and HORMAD2.

3\) Figure 2---figure supplement 2A: data suggest that HORMAD2 FL interacts weakly with SYCP2 compared to the HORMA domain alone (residues 1-241). This suggests that the C-terminal closure motif of HORMAD2 can compete with the SYCP2 closure motif for HORMAD binding. Should test this using the in vitro pull-down assay shown in Figure 2---figure supplement 2C. The competition between closure motifs is likely an important feature of axis assembly/disassembly.

4\) How filaments form is unclear. Which interactions are involved? Specific concerns are also raised by the model of Sycp2/3: using SAXS and XLMS the authors claim that the coiled-coil domains of Hs SYCP3 and SYCP2 form a heterotetramer with parallel SYCP3 molecules that are anti-parallel to (parallel) SYCP2 molecules (i.e. a parallel homo-dimer of anti-parallel heterodimers).

While the antiparallel orientation of SYCP3 with respect to SYCP2 is clearly supported by XLMS, this suggested organization results in a polar tetramer due to the polarized orientation of SYCP3 and SYCP2, respectively. Is there any evidence for such a polar axis core filament?

Can the authors exclude the possibility of an apolar heterotetramer with SYCP3 (and SCYP2) being antiparallel to both, SYCP2 and SYCP3 (i.e. an anti-parallel homo-dimer of anti-parallel heterodimers)?

Can the authors use their structural model to simulate XLMS data for more evidence in support of their model compared to alternatives?

5\) Filament vs bundle. How general is the property to form bundle is unclear and how these bundle are formed is not clear: if the LQSMLF sequence only exists in mammalian SYCP3 (Figure 2H), please comment on how the bundling might occur in yeast and plants since bundling appears to be essential for chromosome axis formation?

6\) Some citations in the Introduction seem arbitrary and the authors should verify that the references listed support their statements. For example, in paragraph four of the Introduction section the authors write \"\[...\] lateral elements of the SC, become linked by coiled-coil transverse filaments along their entire length (Wojtasz et al., 2009, Smith and Roeder, 1997; Börner, Barot and Kleckner, 2008; Joshi et al., 2009, Roig et al., 2010 and Lambng et al., 2015)\". The citations listed here refer to the role of Pch2, not the establishment/existence of transverse filaments.

Likewise, citations (Dunce et al., 2018, Lu et al., 2014, Cahoon et al., 2017, Köhler et al., 2017 and Schücker et al., 2015) do not only show the \"molecular architecture of the SC transverse filaments and associated central element\" but also include super-resolution studies of localizations of components within the lateral element, while a reference to the structure of central element proteins SYCE2-TEX12 (Davies et al., 2012) is missing.

10.7554/eLife.40372.040

Author response

> Essential revisions
>
> Several experiments require clarification and further validations. In addition, some conclusions are highly speculative which is fine for a discussion but should not be presented as conclusions of this study per se and thus should not be included in the Abstract or title. Both title and Abstract should highlight the conclusions of the experiments and should be revised. It does not seem that the mechanism of meiotic chromosome organization is known yet: how filaments and bundles form or dissociate is unknown. How cohesins are build-in to contribute to loop formation is also unknown.

We appreciate that the final sentence in our Abstract contained speculation about how our findings fit into the developing model of chromosome axis assembly. While we would argue that this sentence provided important context for the importance of the study and was not presented in a way that suggests we have demonstrated the claims, we have nonetheless removed this sentence from the Abstract. We hope that the revised Abstract is more satisfactory.

We have also re-written the title to focus more on the findings of the paper, as suggested.

*1) Red1 filaments and their role* in vivo*: the use and test of the chimeric protein (Sc/Zr) is important but a critical test that should be done is to mutate the I715 residue in the chimera.*

> Figure 1H: Please include Sc Red1 wild-type staining for comparison and quantify Red1 staining to support the statement that the construct \"does not affect chromosome localization\" (Figure 1H legend).
>
> Does Sc Red1 I743A (or I743R) load onto chromosome axes as expected? The yeast imaging is only partially convincing. Protocols are available to actually see the Red1 axis by spreading nuclei which would be much more informative about the consequence of the mutations tested.

The reviewer is correct that the data presented in the original Figure 1H was not strong. The microscopy samples were in fact prepared using a popular spreading technique (Grubb... Bishop *JOVE* 2015), but the results were obviously less than ideal. To overcome these issues, we collaborated with Amy MacQueen (Wesleyan University) to perform high-quality imaging of wild-type *Sc* Red1 and three *Sc/Zr* chimeras: full-length (including residues 707-798 of *Zr* Red1), 707-791, and the 707-798(I715R) mutant as suggested. The results are presented in the new Figure 1H-I, and Figure 1---figure supplement 3. We imaged both Red1 and Gmc2, a component of the synaptonemal complex central element, in all strains. With these much-improved spreads, we observed that the full-length chimera localizes to chromosomes, albeit to a lesser extent than wild-type *Sc* Red1, and supports near-complete synaptonemal complex assembly. Both removal of residues 792-798 and mutation of I715 to R reduced (but did not eliminate) Red1 chromosome localization, and did not support synaptonemal complex assembly. This result is further discussed in the Results section.

Unfortunately, it is not known whether *Sc* Red1 I743A or I743R localizes to chromosomes. In the paper where this mutant was described (Eichinger et al., 2010), the authors showed that the *red1-I743A* strain has extremely low spore viability (5.7%, compared to 87.8% for wild-type *RED1*) and does not assemble synaptonemal complexes (as judged by Zip1 staining). This suggests that the I743A mutant may behave equivalently to our *Sc-Zr* chimera containing the I715R mutant. More is known about the Red1 I758R mutant (Lin et al., 2009), which is also located in the predicted coiled-coil region of Red1. This mutant shows low spore viability (\<1%) and does not assemble synaptonemal complexes, but localizes strongly to meiotic chromosomes.

We compared the size-exclusion profiles of purified *Sc* Red1 (CTD) WT, I743R, and I758R, and found that both mutations strongly disrupt oligomer formation. Indeed I758R, being localized in the middle of the predicted coiled-coil region, appears to disrupt the large assemblies more effectively: I743R causes dissociation to a tetramer form, while I758R causes dissociation to individual monomers. These data were not included in the original manuscript, but are now included in Figure 1---figure supplement 1B, and discussed in subsection "Budding Red1 forms filaments from coiled-coil tetramer units" of the revised manuscript.

> 2\) Clarify how the closure motif is defined and what experiment beyond the interaction data allows for the conclusion of the presence of a closure motif. In Figure 2A: show the sequence alignment of HORMAD-binding closure motifs of SYCP2, HORMAD1 and HORMAD2.

Figure 2A now shows a sequence alignment between the putative closure motifs of *M. musculus* SYCP2, HORMAD1, and HORMAD2. The new Figure 2---figure supplement 3 further shows a multiple-sequence alignment of SYCP2 and HORMAD1, with the motifs aligned as in Figure 2A.

Regarding the definition of a closure motif, we define it as a short sequence that binds to a HORMA domain protein in a manner similar to that of the known "MAD2-interacting motifs" of CDC20 and MAD1 (binding MAD2), or the closure motifs of the *C. elegans* meiotic HORMADs, which we have shown bind these proteins equivalently to MAD2-interacting motifs (Kim et al., 2014). We later showed using biochemical assays and HD-exchange that similar motifs in the *S. cerevisiae* Hop1 C-terminus and Red1 central region bind the Hop1 HORMA domain as closure motifs (West et al., 2018). We do not have direct data indicating that the putative closure motifs in mammalian and plant axis proteins are *bona fide* closure motifs. We are comfortable calling them closure motifs based on the following extremely strong circumstantial evidence:

1\) HORMA domains are well-known to bind short peptide motifs in one and only one way.

2\) We have identified short peptides that specifically bind the HORMA domain of meiotic HORMADs in both families.

3\) These motifs form stable complexes with their respective HORMA domain partners in co-expression analysis (Figure 2---figure supplement 2C and Figure 5C).

4\) The identified motifs are located similarly to the verified closure motifs in *S. cerevisiae*: at the extreme C-terminus of the HORMADs themselves, and immediately following an ordered N-terminal domain in the axis core proteins. As plant ASY3 lacks this ordered N-terminal domain, the identified closure motif is at the extreme N-terminus of this protein.

Finally, the biochemical data presented in the next response (and in the new Figure 2---figure supplement 2D) further supports that these are indeed closure motifs.

*3) Figure 2---figure supplement 2A: data suggest that HORMAD2 FL interacts weakly with SYCP2 compared to the HORMA domain alone (residues 1-241). This suggests that the C-terminal closure motif of HORMAD2 can compete with the SYCP2 closure motif for HORMAD binding. Should test this using the* in vitro *pull-down assay shown in Figure 2---figure supplement 2C. The competition between closure motifs is likely an important feature of axis assembly/disassembly.*

The reviewer is correct that the putative closure motif on the HORMAD2 C-terminus likely competes for binding the HORMA domain with the putative closure motif on SYCP2. We have previously shown that in *S. cerevisiae*, the Hop1 HORMA domain binds more strongly to the closure motif on Red1 than the closure motif on its own C-terminus (West et al., 2018). The reviewer is right to ask for similar analysis in the mammalian proteins. Unfortunately, the pulldown assay shown in Figure 2---figure supplement 2C was performed with the two proteins co-expressed in *E. coli*, then purified, making it non-ideal for the competition assay the reviewer suggests. Instead, we purified the HORMAD2 HORMA domain (residues 1-241) and tested its binding to a peptide encoding the HORMAD2 closure motif (residues 282-306), and measured a *Kd* of \~ 7 uM, in line with prior measurements for *C. elegans* and *S. cerevisiae* meiotic HORMADs binding their closure motifs in similar assays (Figure 2---figure supplement 2D). Importantly, we found that a HORMAD2^1-241^:SYCP2^390-429^ complex did not bind the same peptide, showing that the putative closure motifs from SYCP2 and HORMAD2 indeed compete for binding to the HORMAD2 HORMA domain.

> 4\) How filaments form is unclear. Which interactions are involved?

We envision that filaments form from interdigitation of coiled-coil segments of Red1, SYCP2/SYCP3, or ASY3/ASY4 that extend past the core of an individual coiled-coil tetramer. This idea is supported by our finding that truncation of SYCP2, SYCP3, and Red1 all effectively eliminate filament formation but maintain tetramers.

> Specific concerns are also raised by the model of Sycp2/3: using SAXS and XLMS the authors claim that the coiled-coil domains of Hs SYCP3 and SYCP2 form a heterotetramer with parallel SYCP3 molecules that are anti-parallel to (parallel) SYCP2 molecules (i.e. a parallel homo-dimer of anti-parallel heterodimers).
>
> While the antiparallel orientation of SYCP3 with respect to SYCP2 is clearly supported by XLMS, this suggested organization results in a polar tetramer due to the polarized orientation of SYCP3 and SYCP2, respectively. Is there any evidence for such a polar axis core filament?

The reviewer is correct that in our model, the SYCP2:SYCP3 and ASY3:ASY4 filaments (but not those of Red1) would be polar. At present, there is no additional data (in vitro or in vivo) supporting this idea.

> Can the authors exclude the possibility of an apolar heterotetramer with SYCP3 (and SCYP2) being antiparallel to both, SYCP2 and SYCP3 (i.e. an anti-parallel homo-dimer of anti-parallel heterodimers)?
>
> Can the authors use their structural model to simulate XLMS data for more evidence in support of their model compared to alternatives?

We have favored a model in which the SYCP2:SYCP3 heterotetramer is built with two parallel SYCP2 monomers, arranged antiparallel to two SYCP3 monomers ("parallel antiparallel" model in Figure 4---figure supplement 3A) It is also possible that a 2:2 heterotetramer could form with a pair of antiparallel SYCP2 protomers, and a pair of antiparallel SYCP3 protomers ("antiparallel antiparallel" model in Figure 4---figure supplement 3A). We used two methods to distinguish between these models.

First, we systematically modeled parallel versus antiparallel arrangements of SYCP2-SYCP2, SYCP3-SYCP3, and SYCP2-SYCP3, identified those lysine pairs predicted to be within 20 or 30 Å of one another (and would therefore be expected to form crosslinks in XLMS), and compared these predictions to our XLMS data. This data is presented in the attached Microsoft Excel workbook listed as Table S4. While noisy and incomplete, the XLMS data generally support a parallel arrangement for SYCP2-SYCP2 interactions, a parallel arrangement for SYCP3-SYCP3 interactions, and an antiparallel arrangement for SYCP2-SYCP3 interactions. This data is most consistent with the "parallel antiparallel" model.

Second, we performed SAXS analysis on our fused SYCP3^CC^-SYCP2^CC^ construct, this time with an intact N-terminal maltose-binding protein tag (\~43 kDa). The two MBP tags are located on the same end of the tetramer in the "parallel-antiparallel" model, and on opposite ends in the "antiparallel-antiparallel" model. Given the size of MBP, these two possibilities are easily distinguished by SAXS. The new data, shown in Figure 4---figure supplement 3 and discussed in subsection "SYCP2 is an interaction hub for the mammalian chromosome axis" of the revised manuscript, clearly indicates that the MBP tags are on the same end of the tetramer, further supporting the "parallel-antiparallel" model.

> 5\) Filament vs bundle. How general is the property to form bundle is unclear and how these bundle are formed is not clear: if the LQSMLF sequence only exists in mammalian SYCP3 (Figure 2H), please comment on how the bundling might occur in yeast and plants since bundling appears to be essential for chromosome axis formation?

While we agree with the reviewer that the observed bundling of mammalian SYCP2:SYCP3 filaments raises several questions, we have not explored this behavior extensively enough to adequately answer these questions. In particular, the tendency to form bundles does not appear to be shared by budding-yeast or plant meiotic axis core protein filaments, suggesting that bundling, if indeed it does occur in cells, may be specific to mammals. We have added a note to this effect in subsection "SYCP2 is an interaction hub for the mammalian chromosome axis".

> 6\) Some citations in the Introduction seem arbitrary and the authors should verify that the references listed support their statements. For example, in paragraph four of the Introduction section the authors write \"\[...\] lateral elements of the SC, become linked by coiled-coil transverse filaments along their entire length (Wojtasz et al., 2009, Smith and Roeder, 1997; Börner, Barot and Kleckner, 2008; Joshi et al., 2009, Roig et al., 2010 and Lambng et al., 2015)\". The citations listed here refer to the role of Pch2, not the establishment/existence of transverse filaments.

We apologize for this error. We have changed the references cited for this sentence.

> Likewise, citations (Dunce et al., 2018, Lu et al., 2014, Cahoon et al., 2017, Köhler et al., 2017 and Schücker et al., 2015) do not only show the \"molecular architecture of the SC transverse filaments and associated central element\" but also include super-resolution studies of localizations of components within the lateral element, while a reference to the structure of central element proteins SYCE2-TEX12 (Davies et al., 2012) is missing.

We apologize for leaving out this important reference. We have altered the wording of the sentence in question to better reflect our original intent, and also added the Davies et al. reference. We have also carefully checked all references in the manuscript to ensure that they are used properly.
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